spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  brain lesions 

 HSMN NewsFeed - 3 Feb 2020
7D Surgical Expands Spine and Cranial Technology Offering
Devices Neurosurgery FDA Product Launch
 HSMN NewsFeed - 17 Jan 2019
First Cancer Patients in Taiwan Treated with Varian HyperArc High-Definition Radiotherapy
Devices Oncology
 HSMN NewsFeed - 26 Dec 2018
Venus Medtech Completes Merger with Keystone Heart, Ltd.
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 23 Oct 2018
Monteris(R) Medical Announces FDA Clearance of Laser Probe with Fiber Optic Controlled Cooling for Use with the NeuroBlate(R) System
Devices Neurosurgery FDA
 HSMN NewsFeed - 25 Sep 2018
Venus Medtech Announces Agreement to Acquire Keystone Heart, LTD
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 2 Mar 2017
Keystone Heart and Venus Medtech Announce Partnership for Cerebral Embolic Protection with Transcatheter Heart Valve Systems (TAVR) in China and Key Asian Markets
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Dec 2016
Positive Phase III Results of Genentech’s Investigational Medicine OCREVUS(TM) (Ocrelizumab) Published in New England Journal of Medicine
Biopharmaceuticals Neurology
 HSMN NewsFeed - 9 Dec 2016
Biogen and AbbVie Receive Health Canada Approval of Once-Monthly ZINBRYTA(TM) (Daclizumab Beta) for Multiple Sclerosis
Biopharmaceuticals Nerurology Regulatory
 HSMN NewsFeed - 8 Sep 2016
Monteris Medical Receives IDE Approval From FDA To Evaluate NeuroBlate(R) In Patients Newly Diagnosed With Glioblastoma Multiforme
Devices Oncology Neurosurgery FDA
 HSMN NewsFeed - 19 Jul 2016
Monteris Medical Announces Appointment Of Martin J. Emerson As President and Chief Executive Officer
Devices Oncology Neurosurgery Personnel
 HSMN NewsFeed - 19 May 2016
Elekta Surpasses One Million Patients Treated with Leksell Gamma Knife
Devices Oncology Neurosurgery
 HSMN NewsFeed - 13 Nov 2014
Monteris Medical Announces $30 Million Equity Financing
Devices Neurosurgery Venture Capital
 HSMN NewsFeed - 6 Oct 2014
Claret Medical Announces First Patient Treated in U.S. Pivotal Trial Evaluating Cerebral Protection During Transcatheter Aortic Valve Replacement (TAVR)
Devices Interventional Cardiology
 HSMN NewsFeed - 19 Dec 2013
Nexstim’s Navigated Brain Stimulation Shown to Improve Patient Outcomes in Challenging Brain Surgery
Devices Neurosurgery
 HSMN NewsFeed - 22 Oct 2013
Monteris Medical Announces $13 Million Financing
Devices Neurosurgery Venture Capital
 HSMN NewsFeed - 4 Oct 2013
New TECFIDERA(R) (Dimethyl Fumarate) Data Show Sustained Efficacy and Long-Term Safety in a Broad Range of Multiple Sclerosis Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 28 Jun 2013
Genzyme Receives Positive CHMP Opinion for LEMTRADA(TM) (alemtuzumab) in Europe
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 21 May 2013
Biogen Idec Submits Application to FDA for Approval of PLEGRIDY(TM) (Peginterferon Beta-1a) in Multiple Sclerosis
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 8 Apr 2013
Monteris Medical’s NeuroBlate System Receives 510(k) Clearance
Devices Neurosurgery FDA
 HSMN NewsFeed - 3 Apr 2013
Monteris Medical's AutoLITT- NeuroBlate System for Brain Tumors Receives Regulatory Approval in Canada
Devices Neurosurgery Regulatory
 HSMN NewsFeed - 28 Jan 2013
Genzyme’s LEMTRADA(TM) (alemtuzumab) Application for MS Accepted for Review by the FDA
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 12 Oct 2012
New Data from Phase 3 Studies Provide Additional Evidence Supporting Treatment Effect for Oral BG-12 (Dimethyl Fumarate) in Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 11 Apr 2012
Varian Medical Systems to Showcase TrueBeam(TM) STx with RapidArc(R) Radiosurgery - Technology for Fast, Precise Stereotactic Radiosurgery - at AANS Meeting
Devices Neurosurgery Oncology
 HSMN NewsFeed - 5 Oct 2011
Major Diagnostic Breakthrough in Multiple Sclerosis Achieved with Advanced FONAR UPRIGHT(R) MRI
Devices Radiology Neurology
 HSMN NewsFeed - 30 Mar 2011
Study Shows Gamma Knife Radiosurgery for Patients With Multiple Brain Metastases is Best for Sparing Healthy Tissue
Devices Oncology Neurosurgery
 HSMN NewsFeed - 22 Sep 2010
Novartis gains FDA approval for Gilenya, a novel first-line multiple sclerosis treatment shown to significantly reduce relapses and delay disability progression
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 19 Aug 2010
Treatment with Elekta's Leksell Gamma Knife Perfexion Introduced to Cancer Patients in Australia
Devices Oncology Neurosurgery
 HSMN NewsFeed - 7 Jun 2010
Teriflunomide in Adjunct to Interferon Beta Significantly Improved Outcomes of Multiple Sclerosis Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 1 Oct 2009
Saint Joseph's Hospital First in Georgia to Offer Noninvasive Treatment of Brain Disorders with Leksell Gamma Knife Perfexion
Devices Oncology
 HSMN NewsFeed - 8 Jul 2009
Biogen Idec Receives Fast Track Designation from FDA for PEGylated Interferon Beta-1a for Relapsing Multiple Sclerosis
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 22 Sep 2008
Results From IMPROVE Study Show Therapeutic Effect of New Formulation of Rebif(R) at 16 Weeks in Patients With Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 26 May 2008
Elekta: Leksell Gamma Knife(R) Perfexion(TM) Receives Regulatory Approval in Japan
Devices Oncology Regulatory
 HSMN NewsFeed - 24 Apr 2008
Elekta's New Line of Stereotactic Treatment Solutions is Redefining Excellence in Stereotaxy, a Case at a Time
Devices Neurosurgery
 HSMN NewsFeed - 1 Feb 2008
MediciNova's MN-166 Reduces Persistent Black Hole Formation in Multiple Sclerosis Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 3 Jun 2007
Glaxosmithkline Reports Positive New Data on Tykerb(R)(Lapatinib) at the 2007 American Society of Clinical Oncology (ASCO) Annual Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 May 2007
Treatment with COPAXONE(R) Plus Minocycline Showed Substantial Reduction of Disease Activity in Patients with Active Relapsing-Remitting Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 20 Dec 2006
FDA Approves New Indication for INVANZ(R) (ertapenem) for the Prevention of Surgical Site Infections (SSI) following Elective Colorectal Surgery in Adults
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Nov 2006
Betaferon(R) Approved in Australia for Earliest Stages of Multiple Sclerosis
Biopharmaceuticals Regulatory Neurology
 HSMN NewsFeed - 9 Oct 2006
Brain Surgery at its Most Precise: Leksell Gamma Knife(R) Perfexion(TM), from Elekta, Provides New Levels of Patient Comfort and Physician Convenience
Devices Neurosurgery
 HSMN NewsFeed - 29 Sep 2006
Study Showed Significant and Sustained Efficacy Of COPAXONE(R) Alone Following Short-Term Combination Therapy With IV Steroids in Multiple Sclerosis Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 19 Sep 2006
Physicians at the University of California, San Diego Deliver Non-Invasive Neurosurgery Using Image-Guidance Tools From Varian Medical Systems
Devices Oncology Neurosurgery
 HSMN NewsFeed - 31 May 2006
Biogen Idec to Acquire Fumapharm AG
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 30 May 2006
Oral Compound BG-12 Achieves Primary Endpoint in Phase II Study of Relapsing-Remitting Multiple Sclerosis
Biopharmaceuticals Neurology
Return to NewsFeed  

 Additional items found! 23

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 23 additional stories matching:
brain lesions
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.